Literature DB >> 21674312

Infective endocarditis in a child caused by Cardiobacterium hominis after right ventricular outflow tract reconstruction using an expanded tetrafluoroethylene conduit.

Yoshiyuki Maekawa1, Takahiko Sakamoto, Kentaroh Umezu, Noburoh Ohashi, Yorikazu Harada.   

Abstract

Cardiobacterium hominis, a member of the HACEK group of organisms, is a rare cause of endocarditis. We report a case of infective endocarditis caused by C. hominis in a male child who had undergone right ventricular outflow tract (RVOT) reconstruction using an expanded polytetrafluoroethylene conduit for tetralogy of Fallot with pulmonary atresia. Two days before admission, the patient suffered from exertional shortness of breath. Right ventricular hypertension was confirmed and RVOT stenosis was suspected based on the echocardiography findings. A CT scan revealed vegetation above the cusp of the conduit. An emergency operation was performed to avoid a pulmonary embolism due to large friable vegetation. C. hominis was cultured from the blood and the vegetation, prompting a diagnosis of prosthetic valve endocarditis. The patient was discharged after a 6-week course of intravenous ceftriaxone therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674312     DOI: 10.1007/s11748-010-0707-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  15 in total

1.  Diagnosis of Cardiobacterium hominis endocarditis by broad-range PCR from arterio-embolic tissue.

Authors:  N J Mueller; V Kaplan; R Zbinden; M Altwegg
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  FURTHER CHARACTERIZATION OF AN UNCLASSIFIED GROUP OF BACTERIA CAUSING ENDOCARDITIS IN MAN: CARDIOBACTERIUM HOMINIS GEN. ET SP. N.

Authors:  I J SLOTNICK; M DOUGHERTY
Journal:  Antonie Van Leeuwenhoek       Date:  1964       Impact factor: 2.271

3.  FLUORESCENT ANTIBODY DETECTION OF HUMAN OCCURRENCE OF AN UNCLASSIFIED BACTERIAL GROUP CAUSING ENDOCARDITIS.

Authors:  I J SLOTNICK; J A MERTZ; M DOUGHERTY
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

4.  Endocarditis caused by a Pasteurella-like organism; report of four cases.

Authors:  D N TUCKER; I J SLOTNICK; E O KING; B TYNES; J NICHOLSON; L CREVASSE
Journal:  N Engl J Med       Date:  1962-11-01       Impact factor: 91.245

5.  Endocarditis due to beta-lactamase-producing Cardiobacterium hominis.

Authors:  A Le Quellec; D Bessis; C Perez; A J Ciurana
Journal:  Clin Infect Dis       Date:  1994-11       Impact factor: 9.079

6.  Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy.

Authors:  T M Pritchard; R T Foust; J R Cantely; R B Leman
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

7.  Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad-range bacterial PCR.

Authors:  N Gatselis; E Malli; G Papadamou; E Petinaki; G N Dalekos
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 8.  Late aortic homograft valve endocarditis caused by Cardiobacterium hominis: a case report and review of the literature.

Authors:  P F Currie; M Codispoti; P S Mankad; M J Godman
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

9.  Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases.

Authors:  J E Geraci; W R Wilson
Journal:  Mayo Clin Proc       Date:  1982-03       Impact factor: 7.616

10.  Cardiobacterium hominis: review of microbiologic and clinical features.

Authors:  G P Wormser; E J Bottone
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug
View more
  2 in total

1.  Right-sided infective endocarditis: recent epidemiologic changes.

Authors:  Shi-Min Yuan
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Cardiobacterium hominis-induced acute dacryocystitis and lacrimal abscess.

Authors:  Guru Prasad Manderwad; Manjulatha Kodiganti; Mohammad Javed Ali
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.